Spyre Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2016 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Spyre Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2016 to Q3 2024.
  • Spyre Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 1, 2024 was 51.4M shares, a 1170% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 51.4M +47.4M +1170% Nov 1, 2024 10-Q/A 2024-11-18
Q2 2024 50.8M -50.4M -49.8% Aug 1, 2024 10-Q/A 2024-11-18
Q1 2024 40.3M -25.1M -38.4% May 1, 2024 10-Q/A 2024-11-18
Q3 2023 4.05M -57.5M -93.4% Nov 3, 2023 10-Q 2023-11-09
Q2 2023 101M +40M +65.4% Aug 4, 2023 10-Q 2023-08-11
Q1 2023 65.4M +15M +29.7% May 2, 2023 10-Q 2023-05-11
Q3 2022 61.5M +12.2M +24.7% Oct 28, 2022 10-Q 2022-11-03
Q2 2022 61.2M +12.1M +24.7% Jul 29, 2022 10-Q 2022-08-04
Q1 2022 50.4M +2.4M +5.01% Apr 28, 2022 10-Q 2022-05-05
Q3 2021 49.3M +1.38M +2.89% Oct 28, 2021 10-Q 2021-11-04
Q2 2021 49.1M +4.46M +10% Jul 30, 2021 10-Q 2021-08-05
Q1 2021 48M +3.42M +7.67% Mar 12, 2021 10-K 2021-03-18
Q3 2020 47.9M +19M +65.4% Nov 2, 2020 10-Q 2020-11-05
Q2 2020 44.6M +15.7M +54.4% Aug 5, 2020 10-Q 2020-08-10
Q1 2020 44.6M +15.8M +54.7% May 1, 2020 10-Q 2020-05-07
Q3 2019 29M +5.02M +21% Nov 1, 2019 10-Q 2019-11-06
Q2 2019 28.9M +6.89M +31.3% Aug 1, 2019 10-Q 2019-08-06
Q1 2019 28.8M +12.1M +72.4% Mar 1, 2019 10-K 2019-03-07
Q3 2018 24M +7.32M +44% Nov 2, 2018 10-Q 2018-11-08
Q2 2018 22M +5.54M +33.7% Aug 3, 2018 10-Q 2018-08-09
Q1 2018 16.7M +3.26M +24.3% Mar 8, 2018 10-K 2018-03-13
Q3 2017 16.6M +3.21M +23.9% Nov 3, 2017 10-Q 2017-11-07
Q2 2017 16.5M +3.04M +22.7% Aug 7, 2017 10-Q 2017-08-09
Q1 2017 13.5M Mar 23, 2017 10-K 2017-03-23
Q3 2016 13.4M Nov 9, 2016 10-Q 2016-11-09
Q2 2016 13.4M Aug 8, 2016 10-Q 2016-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.